Surgery Clinical Trial
Official title:
Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol A) in Oral Surgery Patients B) in General Dentistry Patients C) in Colonoscopy Patients
Whether patient-maintained sedation (the patient controls his/her degree of sedation using a hand-held device) using the drug propofol is safer and more effective when using deteriorating reaction time as an added safeguard against the potential for over sedation in a groups of patients undergoing oral surgery, general dentistry and colonoscopy.
Patients receiving conscious sedation for dentistry and endoscopy are usually treated with
intermittent bolus doses of intravenous midazolam (administered by the
operator-sedationist). The safety of such a regime has been questioned with reports of up to
13 % of patients desaturating to below 80 % in the recovery area following sedation for
endoscopy. Mortality occurs in 0.05 % of endoscopy patients (with approximately 60 % of this
being due to hypoxaemia). The aim of our work, therefore, is to look at providing sedation
that is both safer as well as being efficacious.
The drug propofol, the agent most commonly used to induce general anaesthesia in the UK, is
also frequently administered intravenously by anaesthetists in low doses to provide
conscious sedation for patients undergoing unpleasant procedures i.e. patients become
relaxed, anxiety-free, but maintain verbal contact throughout.
The technique of patient maintained sedation using the drug propofol (the patient can
increase the amount of sedation (and propofol) they receive by pressing a demand button
attached to a standard infusion device) has been used by anaesthetists and evaluated since
1997.
Several recent studies published and submitted for publication by this research group on
patient maintained sedation using the drug propofol have shown this method of sedation to be
safe and effective in dental patients (over 120 patients studied). It was also shown that
this method, when compared to the established method of sedation in oral surgery (the
dentist administering doses of midazolam intravenously), to produce both quicker recovery
and less anxiety prior to the surgery.
The routine use of propofol traditionally is restricted to anaesthetists, as in high doses
general anaesthesia is produced with possible loss of airway patency. Currently the safety
feature is predominantly that as patients become more sedated they cannot press the patient
demand button and hence cannot increase the amount of propofol they are receiving. Also the
device ensures that the blood and brain concentrations have equilibrated to within 10% of
each other before another successful demand for propofol can be made (usually takes
approximately two minutes) and it only allows a maximum calculated brain concentration of 3
micrograms/milliliter of propofol. The device also will start to decrease the calculated
brain concentration of propofol if the demand button has not been pressed for six minutes.
Despite the encouraging results above we also found in a recent pilot study involving 20
healthy volunteers who were instructed to try and make themselves unconscious that there
were 2 cases of over sedation (of these one briefly lost verbal contact and the other
required supplemental oxygen only). Over sedation, however, was not demonstrated with any of
the oral surgery patients in the previous studies. This may have been due to a higher level
of anxiety in dental patients affecting response to propofol.
We have therefore incorporated an additional safety feature into the existing and previously
studied patient maintained sedation system which may further decrease or eliminate this
small risk of over sedation. All the above safety features are retained and in addition the
patient demand button will now also be used to monitor reaction time at one minutely
intervals.
It is known that propofol slows the reaction time of a given individual and in another
recent study of 40 patients undergoing general anaesthesia for planned surgery using
propofol, the patients’ reaction times were recorded both awake and during induction of
anaesthesia by instructing the patients to press a button as quickly as possible in response
to the handset vibrating. The calculated effect site (brain) concentration of propofol was
increased incrementally and reaction time monitored at each stage until the patient could no
longer press the button.
The data from this study (deteriorating patient reaction time with increased brain
concentration of propofol) was analysed and this information used to provide an additional
safety feature within the system to prevent over sedation i.e. a patient’s reaction time
deterioration by a certain percentage will prevent himself or herself being able to
self-administer more propofol. Furthermore the system will actually start to decrease the
brain concentration of propofol once the patients’ reaction time becomes too slow. The
patient demand button will be used to monitor reaction time at one minutely intervals as
well as administer more propofol.
We hope that this will eliminate the small risk of over sedation and wish to conduct pilot
studies to assess the safety and efficacy of this reaction time safeguarded,
patient-maintained sedation system in three groups of twenty patients requiring sedation for
planned procedures.
We have chosen two groups of dental patients, one group having oral surgery (technically
more difficult dental work e.g. wisdom tooth removal) and one group having routine dentistry
(e.g. patients having tooth fillings who are referred for sedation due to high anxiety
levels). Another of our outcome measures will look at the effect of this technique on the
patients’ anxiety levels and we believe that this technique may be beneficial in reducing
anxiety levels.
Patient maintained sedation has also been studied in 20 colonoscopy patients and found to be
efficacious. However there were also 4 cases of slight over sedation, none of whom required
any intervention e.g. airway or circulatory. We hope that by incorporating the reaction time
safeguard that we can again eliminate this small risk.
;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT03213314 -
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
|
N/A | |
Enrolling by invitation |
NCT05534490 -
Surgery and Functionality in Older Adults
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Terminated |
NCT04612491 -
Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
|
||
Recruiting |
NCT06397287 -
PROM Project Urology
|
||
Recruiting |
NCT04444544 -
Quality of Life and High-Risk Abdominal Cancer Surgery
|
||
Completed |
NCT04204785 -
Noise in the OR at Induction: Patient and Anesthesiologists Perceptions
|
N/A | |
Completed |
NCT03432429 -
Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
|
||
Completed |
NCT04176822 -
Designing Animated Movie for Preoperative Period
|
N/A | |
Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
Not yet recruiting |
NCT05467319 -
Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
|
Phase 3 | |
Recruiting |
NCT04602429 -
Children's Acute Surgical Abdomen Programme
|
||
Completed |
NCT03124901 -
Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor
|
N/A | |
Completed |
NCT04595695 -
The Effect of Clear Masks in Improving Patient Relationships
|
N/A | |
Recruiting |
NCT06103136 -
Maestro 1.0 Post-Market Registry
|
||
Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
Completed |
NCT04059328 -
Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
|
||
Recruiting |
NCT03697278 -
Monitoring Postoperative Patient-controlled Analgesia (PCA)
|
N/A |